TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED FOR ACCUMULATION OF DENDRITIC CELLS IN DRAINING LYMPH-NODES AND FOR OPTIMAL CONTACT SENSITIZATION

被引:0
|
作者
CUMBERBATCH, M
KIMBER, I
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Following skin sensitization epidermal Langerhans' cells (LC), many of which bear antigen, are stimulated to migrate from the skin and traffic via afferent lymphatics to lymph nodes draining the site of exposure. It has been proposed previously that tumour necrosis factor-alpha (TNF-alpha), a keratinocyte-derived epidermal cytokine (the expression of which is augmented following cutaneous sensitization), provides one signal for LC migration. In the experiments described here the influence of systemically administered neutralizing anti-TNF-alpha antibody on dendritic cell (DC) accumulation in draining lymph nodes has been investigated. Treatment with anti-TNF-alpha inhibited markedly the frequency of DC in draining nodes measured 18 hr following exposure to the skin allergens oxazolone and fluorescein isothiocyanate or to the non-sensitizing skin irritant sodium lauryl sulphate. Similar treatment with anti-TNF-alpha 2 hr prior to primary exposure to oxazolone impaired significantly the efficiency of skin sensitization measured 5 days later as a function of challenge-induced increases in ear thickness. The same antibody administered 18 hr following initial exposure to oxazolone was without effect on skin sensitization. These data confirm the importance of TNF-alpha for the migration of LC from the skin to draining lymph nodes and demonstrate that this cytokine is required for optimal contact sensitization.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 50 条
  • [31] Mast cell–derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection
    James B McLachlan
    Justin P Hart
    Salvatore V Pizzo
    Christopher P Shelburne
    Herman F Staats
    Michael D Gunn
    Soman N Abraham
    Nature Immunology, 2003, 4 : 1199 - 1205
  • [32] CHANGE OF MEMBRANE-POTENTIAL IS NOT REQUIRED FOR THE TUMOR-NECROSIS-FACTOR-ALPHA MEDIATED CYTOTOXICITY
    KONG, SK
    CHAN, PC
    CHOY, YM
    FUNG, KP
    LEE, CY
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1993, 15 (01) : 57 - 68
  • [33] EVIDENCE THAT CUTANEOUS ANTIGEN-PRESENTING CELLS MIGRATE TO REGIONAL LYMPH-NODES DURING CONTACT SENSITIZATION
    KRIPKE, ML
    MUNN, CG
    JEEVAN, A
    TANG, JM
    BUCANA, C
    JOURNAL OF IMMUNOLOGY, 1990, 145 (09): : 2833 - 2838
  • [34] T-CELLS WHICH DO NOT EXPRESS MEMBRANE TUMOR-NECROSIS-FACTOR-ALPHA ACTIVATE MACROPHAGE EFFECTOR FUNCTION BY CELL CONTACT-DEPENDENT SIGNALING OF MACROPHAGE TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION
    SUTTLES, J
    MILLER, RW
    TAO, X
    STOUT, RD
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (08) : 1736 - 1742
  • [35] SUPERANTIGEN-INDUCED DIFFERENTIATION OF ANTITUMOR T-CELLS FROM TUMOR-DRAINING LYMPH-NODES
    FOX, BA
    ELSHOLZ, DD
    CAMERON, MJ
    SHU, S
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A59 - A59
  • [36] TUMOR NECROSIS FACTOR CACHECTIN AND LYMPHOTOXIN GENE-EXPRESSION IN LYMPH-NODES FROM LYMPHOMA PATIENTS
    SAPPINO, AP
    SEELENTAG, W
    PELTE, MF
    ALBERTO, P
    VASSALLI, P
    BLOOD, 1990, 75 (04) : 958 - 962
  • [37] DIFFERENTIAL-EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA ON ENDOTHELIAL-CELLS
    HOVING, JB
    WILLIAMS, SK
    FASEB JOURNAL, 1991, 5 (04): : A526 - A526
  • [38] EPENDYMAL CELLS OF THE CHOROID-PLEXUS EXPRESS TUMOR-NECROSIS-FACTOR-ALPHA
    TARLOW, MJ
    JENKINS, R
    COMIS, SD
    OSBORNE, MP
    STEPHENS, S
    STANLEY, P
    CROCKER, J
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1993, 19 (04) : 324 - 328
  • [39] Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection
    McLachlan, JB
    Hart, JP
    Pizzo, SV
    Shelburne, CP
    Staats, HF
    Gunn, MD
    Abraham, SN
    NATURE IMMUNOLOGY, 2003, 4 (12) : 1199 - 1205
  • [40] EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA ON NORMAL FELINE HEMATOPOIETIC PROGENITOR CELLS
    KHAN, KNM
    KOCIBA, GJ
    WELLMAN, ML
    REITER, JA
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (07) : 900 - 903